Savitra Bandari
Neurology with Special Qualifications in Child Neurology · Edison, NJNPI 1306005038
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $861, more than ten times the $35 reported in 2019.
Across 86 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$189
- SK Life Science, Inc.$131
- AbbVie$108
- Supernus Pharmaceuticals, Inc.$107
- Averitas Pharma Inc.$102
- Argenx US, Inc.$84
- plus $685 from 21 others
What the payments were for
- Food & beverage$1,407100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 11 | $189 |
| SK Life Science, Inc. | 8 | $131 |
| AbbVie | 7 | $108 |
| Supernus Pharmaceuticals, Inc. | 7 | $107 |
| Averitas Pharma Inc. | 6 | $102 |
| Argenx US, Inc. | 5 | $84 |
| Johnson & Johnson(2 entities) | 5 | $78 |
| Neurelis, Inc. | 4 | $64 |
| Grifols USA, LLC | 4 | $59 |
| AstraZeneca(2 entities) | 3 | $52 |
| Otter Pharmaceuticals, LLC | 3 | $47 |
| Tris Pharma Inc | 3 | $41 |
| Medtronic | 1 | $41 |
| Biogen | 2 | $36 |
| Ironshore Pharmaceuticals Inc. | 2 | $35 |
| Springworks Therapeutics, Inc. | 2 | $34 |
| Aucta Pharmaceuticals, Inc. | 3 | $29 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Theragen, Inc. | 1 | $17 |
| Immedica Pharma US, Inc. | 1 | $17 |
| Octapharma USA, Inc. | 1 | $16 |
| CSL Behring | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Greenwich Biosciences, Inc. | 1 | $14 |
How this compares
$1,407 in reported general payments places this provider in the 70th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Other neurology with special qualifications in child neurology in Edison
- Yongming MaoEdison$2K
- Mohammed NizamEdison$309
- Juliann PaolicchiHackensack$80K
- Trevor DesouzaMorristown$14K
- Rao PasupuletiHamilton$11K
- Aliza AlterLivingston$9K
- Sara RubensteinHackensack$7K
- Carlos LastraNew Brunswick$5K
- Jacqueline RomeroMarlboro$4K
- Sohum TrivediMarlboro$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.